Insulet | PODD - Debt

Stock Price
251.24
Daily Change
0.02 0.01%
Monthly
-11.38%
Yearly
-11.75%
Q1 Forecast
247.93

Insulet reported $1.4B in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Align Technology USD 121.27M 1.75M Sep/2025
AtriCure USD 77.25M 15.39M Jun/2025
Avanos Medical USD 137.3M 29.9M Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cardinal Health USD 8.53B 848M Jun/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Dexcom USD 2.45B 132.5M Sep/2025
Edwards Lifesciences USD 702.6M 3.2M Jun/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Globus Medical USD 121.1M 120.63M Jun/2025
ICU Medical USD 1.39B 148.5M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 28.61B 93M Jun/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 180.08M Jun/2025
West Pharmaceutical Services USD 202.7M 100K Sep/2025
Zimmer Biomet Holdings USD 8.11B 540.1M Sep/2025